Nivolumab only slightly increased the killing of untreated NPC cells brought about by IFNβ-pre-treated NK cells and had no significant effect on the killing of chemotherapy-pretreated NPC cells by non-activated NK cells (Suppl. The gene discussed is IFNB1; the disease is nasopharyngeal carcinoma.